Q3 2024 Vistagen Therapeutics Inc Earnings Call Transcript
Welcome to Vasogen therapeutics fiscal year 2024 Third Quarter Financial Results and Corporate Update. At this time, all participants are in a listen only mode and question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Mark McPartland Senior Vice President, Investor Relations of Visium. Craig, you may begin.
Thank you, Doug, and good afternoon, everyone, and welcome to this region's fiscal year 2020 for third quarter Corporate Update Conference Call and Webcast. This afternoon, we filed our quarterly report and issued a press release providing an overview of our recent third quarter results and our neuroscience pipeline development. We encourage you to review the release, which can be found in the Investor Relations section of the VISTA gene website.
During today's call, we will make forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
